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Abstract 
Introduction: Ischemia, referring to reduction and restriction of perfusion to myocardial tissue which 
involves coronary arteries through the formation of misplaced clots and thrombosis, is one of the most 
important cardiovascular diseases. Plant-based compounds help to improve or prevent disease through 
affecting the factors involved in the disease. This review was conducted to report the medicinal plants 
and factors effective on cardiac ischemia-reperfusion (I/R) injury to supplement the knowledge about 
this disease and its prevention and treatment using certain medicinal plants and their active compounds. 
For this purpose, medicinal plants and their potential antioxidant activities, effects on lipid levels and 
plaque formation, atherosclerosis and development of cardiovascular diseases and ischemia were 
reviewed.  
Methods: To conduct this review, relevant articles published between 1983 and 2018 were retrieved 
from the Google Scholar, PubMed, Scientific Information Database, Web of Science, and Scopus using 
search terms antioxidant, ischemia, reperfusion, heart, infarct, inflammation, cholesterol, and the 
medicinal plants. Then, the eligible articles were reviewed. 
Results: The active compounds of plants including phenolic compounds, flavonoids, and antioxidant 
compounds can be effective on certain pathogenic factors particularly for decreasing cholesterol and 
blood pressure, preventing increases in free radicals and ultimately reducing blood clots and vascular 
resistance to reduce and prevent ischemic disease and its harmful effects. 
Conclusion: Medicinal plants presented in this article appear to be able to prevent cardiac damage and 
disease progression via affecting the factors that are effective on ischemia. 
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INTRODUCTION 
 
Cardiovascular diseases (CVDs) may have various causes such as hypertension, hypoxia, elevated total 
cholesterol, cholesterol, and low-density lipoprotein (LDL), decreased serum high-density lipoprotein 
(HDL) level, diabetes mellitus, increasing age, oxidative stress, and inflammation [1-5]. As one of the 
vital organs of the body, the heart can be exposed to ischemia that causes tissue injury and dysfunction 
[6]. Myocardial infarction (MI) is the most common cause of heart failure that occurs mainly due to a 
sudden reduction in coronary circulation following thrombolytic obstruction in one of the coronary 
arteries already constricted due to atherosclerosis. The incidence of MI is associated with the ST 
segment elevation in the electrocardiogram compared to the isoelectric line. MI is associated with 
certain changes such as cardiomyocytes hypertrophy, myocardial arrhythmia, systolic and diastolic left 
ventricular dysfunction, decreased contractility of the left ventricle, increased fibrosis and apoptosis, 
and reduced capillary density [7].   
 
Physicians seek to find the safest possible pattern in cardiac ischemia-reperfusion (I/R) so that 
contractile function can be restored in the shortest possible time and at the same time irreversible 
damage to muscle cells can be prevented. Unfortunately, reperfusion in the ischemic heart itself causes 
tissue injury referred to as I/R injury. Reperfusion can lead to dangerous and sometimes fatal 
ventricular arrhythmias, such as tachycardia, ventricular fibrillation, and decreased contractility. 
Immediately after reperfusion, necrosis and cell death begin and if perfusion persists, further apoptosis 
and necrosis are continued. This may also result in other complications such as renal impairment [8-
11]. Free radicals can lead to cell death (via apoptotic pathways) and therefore left ventricular 
dysfunction through damaging lysosomes, enzyme membrane, and DNA as well as increasing 
intracellular calcium [12, 13].    
 
In addition, cardiac muscle cells have two enzymatic and non-enzymatic mechanisms to balance 
oxidative stress. Superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPX) are 
the most important antioxidant enzymes. In response to MI, oxidative stress is associated with 
decreased antioxidant enzymes [14]. With alteplase, streplase, urokinase, and streptokinase, 
thrombolytic therapy is used to treat I/R injuries [15-17]. But their side effects such as generalized 
lethicin, effects on misplaced platelets, and allergic reactions have limited their use. Considering the 
increasing prevalence of CVDs and the decreasing age of the incidence of these diseases, it is essential 
to seek out drugs and medicinal plants that can be used routinely in the diet, help control and prevent 
clotting, and also reduce the risk factors for heart diseases and ischemia. Although synthetic drugs have 
desirable effects, they lead to long-term side effects that, in some cases, are transmitted to the next 
generation, while the side effects of herbal medicines are generally lower. This has led to an increase in 
the tendency to use herbal medicines over the last decade. Researchers have also demonstrated the 
positive effects of herbal medicines on cardiac ischemia. Moreover, it has been reported that the use of 
flavonoids and antioxidant compounds is associated with decreased risk of coronary heart disease, 
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atherosclerosis and MI [18, 19].   
 
This review was conducted to report the medicinal plants and factors effective in I/R injury, to 
supplement the knowledge about this disease, its prevention and treatment using certain medicinal 
plants and their active compounds. For this purpose, medicinal plants and their potential antioxidant 
effects, activity on lipid levels and plaque formation, atherosclerosis and development of cardiovascular 
diseases and ischemia were reviewed.  
 
2. MATERIALS AND METHODS   
 
To conduct this review, relevant articles published between 1983 and 2018 were retrieved from the 
Information Sciences Institute (ISI), PubMed, Scientific Information Database (SID), and Scopus using 
the search terms antioxidant, ischemia, reperfusion, heart, infarct, inflammation, cholesterol and 
medicinal plants. Then, the eligible articles were reviewed.  
 
3. RESULTS  
 
3.1. Ischemia Pathology   
 
MI and heart arrhythmia are two fatal complications of coronary artery disease [20]. MI refers to the 
death of myocardial cells due to long-term ischemia. Ischemia refers to the reduction and restriction of 
perfusion to myocardial tissue [21]. Indeed, ischemia is characterized by a lack of oxygen and 
inadequate removal of the metabolites due to reduced perfusion. It usually leads to several biochemical, 
metabolic, functional and morphological changes. Formation of tissue metabolites, particularly organic 
phosphates, decreases contraction intensity by reducing the sensitivity of myofilaments to calcium that 
can lead to death. Such conditions, referred to as ischemic storage, may lead to MI and unstable 
thoracic angina [22].  
 
In response to ischemia, the myocardium causes a shift of aerobic metabolism towards anaerobic 
mechanisms, a reduction in heartbeats in addition to the amount of myocyte shortening during systolic 
contraction through decreased oxygen consumption and therefore the energy reserves decrease. In 
addition, the work of the heart requires the maintenance of energy from oxidative phosphorylation 
pathways in the mitochondria that is much greater than the total content of its ATP, which is the reason 
for cardiac ischemia-reperfusion injury. Clearly, immediately after blockage of the coronary artery or 
cell death, the heart loses its function within a few hours [23]. 
  
 Ionic disturbances and activation of intracellular enzymes can also cause certain damaging changes 
such as the effects of proteases on cellular skeletal proteins and those of lipases on the membrane 
phospholipid components. Lipids also provide a good substrate to form oxygen free radicals through 
the formation of fatty acids, which eventually kills cells by destroying the cell membrane [24]. 
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  Over the past two decades, reperfusion in ischemic myocardium has been considered as one of the 
most important treatments [25]. However, it can cause tissue injury [26]. These injuries (namely I/R 
injuries) are widely varied and lead to life-threatening and sometimes fatal ventricular arrhythmias such 
as tachycardia, ventricular fibrillation, myocyte apoptosis and necrosis, as well as coronary artery 
endothelial injury. Due to this injury, the coronary artery response to vasodilators declines. The 
endothelial injury also causes activation of platelets and leukocytes adhere to the endothelium releasing 
cytotoxic and chemotoxic agents such as leukotrienes, proteases, cytokines and oxygen free radicals in 
the myocardium perfused area through neutrophil migration to the area exacerbating tissue injury [27].   
 
In response to MI, oxidative stress accompanied by cell damage causes an increase in cardiac enzymes 
and decrease in antioxidant enzymes such as SOD, CAT, and GPX [14]. 
 
  Pathophysiological mechanisms include release of oxygen free radicals [28], accumulation of calcium 
[29], activation of the renin angiotensin system [30], activation of neutrophils and inflammation [31], 
accumulation of platelets and products released from them such as thromboxane A2, and activation of 
the complement system [27]. Furthermore, misplaced clots and thromboembolism are developed 
through hemostatic disorders. The thrombosis developed in the circulation due to hemostatic system 
defects cause arterial blockage, atherothrombotic diseases, MI, stroke, and ultimately death [15].  
 
3.2. Epidemiology   
 
CVDs are the most common causes of mortality worldwide. According to the WHO report, annually 
12,000,000 people worldwide die due to CVDs. The prevalence of non-communicable diseases is rising 
in developing countries including Iran, and the burden from CVDs and associated outcomes is 
significant such that CVDs represent the leading cause of death. Although the available data are not 
reliable, approximately 300 people die in Iran each day, according to the Ministry of Health and 
Medical Education. The mortality rate due to CVDs in Iran is the fifth leading one worldwide, and 
therefore Iran has one of the highest mortality rates due to CVDs in the world. MI is the most common 
cause of heart failure [32].    
 
Despite the increased public awareness of the need for prevention of heart disease and the government 
planning for this issue, the number of people who refer to healthcare centers for CVDs is increasing 
every day. Clearly, managers and officials should adopt appropriate viewpoints regarding the 
conditions of patients with cardiac ischemia in the community to do more efficient and accurate 
planning.  A snapshot shows that patients with cardiac ischemia require special services that may not 
only be costly, but will also result in irreversible complications if their reception is delayed. It is 
therefore necessary for health managers and officials to have correct information about the frequency of 
this disease and required services as well as its epidemiological patterns [33].  
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3.3. Etiology   
 
Hypertension and heart valve diseases are the underlying and exacerbating cause of heart failure and 
MI in 65.1% of the cases. MI refers to myocardial cell death due to the loss of circulation and the onset 
of severe and prolonged ischemia. In most cases, arteriosclerosis leads to MI. MI also leads to certain 
changes including cardiomyocytes hypertrophy, myocardial arrhythmia, systolic and diastolic left 
ventricular dysfunction, decreased contractility of the left ventricle, increased fibrosis and apoptosis 
and reduced capillary density [7]. Clinical and experimental work has indicated that the arterial 
endothelium plays a significant role in modulating ventricular dysfunctions and regenerating blood 
vessels in heart failure. In this regard, angiogenesis seems vital for blood re-supply to a region of the 
heart that is affected by hypoxia after MI [34]. 
 
 Angiogenesis refers to the generation of vasculatures from the preexisting ones that are most important 
to the maintenance of the integrity of the vessels for both the process of repairing damaged tissues 
(wound healing) and the formation of lateral vessels in response to myocardial ischemia [35]. In its 
broadest sense, angiogenesis cannot be considered a single process, but rather a complicated process 
that is controlled by the balance between angiogenic and angiostatic factors. Among the angiogenic 
factors, vascular endothelial growth factor (VEGF) is known as the most potent endothelial cell-
specific mitogen that causes growth, proliferation, viability, and migration of the endothelial cells and 
an increase in vascular permeability through receptor tyrosine kinases. The presence of VEGF after MI 
is vital for cardiac angiogenesis and cardiac rescue [36]. Increased availability of nitric oxide (NO) 
improves many of the impaired cardiac processes including angiogenesis. NO, directly and indirectly, 
increases gene expression and the half-life of VEGF and reduces the amount of angiostatin ultimately 
stimulating the process of angiogenesis [37, 38].   
 
Reviews have reported that NO contributes significantly to protecting myocardial arteries and the 
myocardium itself through antioxidant and anti-apoptotic properties, prevention of Ca2+ overload, 
vasodilation, and angiogenesis [36]. In this regard, inhaled NO has been reported to cause a decrease in 
the myocardial tissue size and improve left ventricular function after I/R through decreasing the 
neutrophils [37]. In addition, exacerbating causes such as patient lack of adherence to drug regimes, 
age, sex, alcohol consumption, pulmonary embolism, infection, stress, and hyperthyroidism should all 
be taken into account.  
 
3.4. Diagnosis   
 
Ischemic heart diseases are diagnosed by typical pain, changes in the ECG, echocardiography, and 
medical history. Diagnosis of the disease is also made by determining the levels of total cholesterol, 
high-density lipoprotein, low-density lipoprotein, and triglyceride, blood pressure, and body mass 
index, history of smoking and MI, the severity of angina, and the diagnosis of coronary artery stenosis 
by coronary angiography [39].  
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3.5. Treatment   
 
Recent studies have demonstrated that percutaneous coronary intervention and thrombolytic therapy 
have been used in treating I/R injuries in clinical trials. Thrombolytic agents such as alteplase, 
streplase, urokinase, and streptokinase are also used to treat these patients [15, 17]. These compounds 
have various side effects [18, 40, 41].   
 
Treatment with medicinal plants and their compounds has the potential to prevent acute coronary 
syndromes, cardiac and cerebral ischemia, or ischemia in other tissues through inhibition of coagulant, 
inflammatory, plaque-developing activities, and cardiac enzymes as well as by increasing antioxidant 
enzymes. Regarding this disease, it can be said that many medicinal plants have considerable 
antioxidant potential and can therefore play significant roles in fighting free radicals [42].   
 
The positive effect of a vegetarian diet is confirmed by the slowing down of growth, stopping and 
reversibility of coronary lesions as well as beneficial clinical effects in reducing angina, total 
cholesterol, LDL, and BMI in patients. The main aim of conducting this review is to study and 
introduce these nutritional and herbal compounds with potent antioxidant and hypolipidemic effects, 
and their preventive effects on the formation of free radicals and plaques as well as the development of 
atherosclerosis, CVDs and ischemia.   
 
Table 1 summarizes the studies on the protective effects of medicinal plants on I/R. The botanical 
names, family names, used parts, studied concentrations, and action mechanisms of the plants have also 
been tabulated.   
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Table 1. Effective medicinal plants and compounds on cardiac ischemia-reperfusion 
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4. DISCUSSION   
 
In this article, the positive effects of a number of medicinal plants in preventing heart disease especially 
I/R were reviewed. As already mentioned, medicinal plants and their compounds can cause a decrease 
in injuries due to cardiac ischemia through several pathways in heart and other organs like the kidney 
[71, 72]. The mechanisms involved include increasing oxygen supply to the heart subsequently 
increasing cardiac contractility, lowering blood pressure, decreasing cholesterol, triglyceride, and LDL 
as well as increasing HDL, cholesterol, and apolipoprotein A, reducing lipid peroxidation, MDA, 
calcium, and prostaglandins, dilating coronary arteries, increasing the expression of anti-apoptotic 
genes, reducing necrosis and inflammation, myocardial infarct size, arrhythmias, platelet accumulation, 
fibrinolytic effects, clot lysis, cardiac enzymes creatine kinase, lactate dehydrogenase, 
malondialdehyde, and cardiac troponin I, and increasing antioxidant enzymes such as SOD and GPX. 
The most important mechanism is the antioxidant activity.    
 
Cardiac ischemia causes a shift of aerobic metabolism towards anaerobic mechanisms and reduction in 
heartbeats and the amount of myocyte shortening during contraction.   
 
Evidence also indicates an association of the components of the coagulation system (fibrinogen and 
factor 7) and fibrinolytic factors including tissue plasminogen activator and plasminogen activator 
inhibitor with heart diseases [73]. Zataria moltiflora, Heracleum persicum and Curcuma domestica 
prevent ischemia through fibrinolytic and clot lysis effects [59].   
 
Following ischemia, inflammatory factors are activated, macrophages produce certain cytokines such as 
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interleukin 1(IL 1) and tumor necrosis factor (TNF) that cause enhancement of leukocyte binding, 
platelet accumulation and monocyte chemotactic proteins enhance leukocyte function in atheromatous 
plaques. The free radicals produced from macrophages cause muscle cell proliferation by oxidizing 
LDL. The main complications of this condition are MI and stroke [74]. Most plants introduced in the 
present review and some other ones such as Chichorium intybus and Rosa canin have been reported to 
contribute towards protecting the heart or kidney against ischemia through antioxidant, hypolipidemic, 
hypotensive, anti-inflammatory, and infarct size reducing effects [60, 61, 75, 76].   
 
Hypolipidemia is another risk factor for atherosclerosis and progression of diabetes complications 
especially CVDs and ischemia [77, 78]. Investigations have demonstrated an inverse correlation 
between the use of medicinal plants or polyphenol-rich foods and CVDs. This is related to the ability of 
polyphenols to prevent LDL cholesterol oxidation. For example, Olea europaea, Cinamomum Spp and 
Artemisia dracunculus cause a decrease in cholesterol levels and lipid peroxidation as well as an 
increase in antioxidant enzymes [56, 69, 70].   
 
In addition, beta-glucan, isolated from Hordeum vulgare, decreases cholesterol and LDL, increases 
LDH, and prevents arteriosclerosis and ischemia [45].   
 
In patients with heart disease, arrhythmia is one of the most predisposing factors for heart failure and 
cardiac ischemia. The causes of cardiac arrhythmia involve one or more sets of disorders such as 
disruption of rhythm production by the SA node, the blockage at different points in the pathway of 
impulse transfer in the heart, the production of abnormal impulses, and a change of pacemaker location 
in the cardiac conduction rhythm generating system [13].   
 
Certain medicinal plants such as Crocus sativa can reduce arrhythmia and ischemic complications via 
blocking calcium channels, exerting anti-arrhythmic, hypolipidemic, and antioxidant effects and 
inhibiting tachycardia. In response to MI, oxidative stress, accompanied by cell damage, leads to an 
increase in cardiac enzymes and a decrease in antioxidant enzymes such as SOD, GPO, and CAT [78, 
79]. Lipid peroxidation on unsaturated fatty acids leads to the production of MDA, which can be due to 
the weakness of the antioxidant system [80, 81].   
 
In MI, total LDH levels begin to increase within 2-48 hours and return to normal levels 2-3 days after 
the incidence of MI. Troponin is one of the contractile proteins of muscle including heart muscle. 
Serum troponin levels are used for MI diagnosis [82]. Cardiac troponins consist of troponins T, C, and 
I. In MI patients, cardiac troponins T and I begin to elevate up to three hours after the incidence of MI. 
Troponins T and I remain high for 10-12 and 7-10 days, respectively [83, 84]. For example, Melissa 
officinalis and Allium ursinumon possess potent antioxidant effects and decrease peroxidation of lipids 
such as MDA, cardiac enzyme CTnI, blood pressure, and infarct size [63, 65].    
 
Evidence on heart and renal diseases indicate that flavonoids and phenolic compounds in plants have 
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several biological effects including antioxidant, free radical-scavenging, anti-inflammatory, and 
anticancer activities [85-90]. Many polyphenols including capechin, quercetin and ethanol exert 
supportive effects against vascular diseases that can be attributed to increased fibrinolytic activity and 
the expression of the proteins involved in the fibrinolytic system [91]. These polyphenols cause a 
decrease in lipid peroxidation and enhancement of antioxidant enzyme activity through their 
antioxidant effects [92]. In addition to affecting cardiac ischemia positively, these antioxidant effects of 
the plants lead to optimal effects on many other diseases from which the patient may be suffering.   
Altogether, medicinal plants can be effective in ischemic heart disease through different mechanisms 
and patients with such diseases may be recommended to use these plants.  
 
CONCLUSION    
 
This article reveals that there is a negative correlation between the use of medicinal plants, full of 
antioxidant polyphenols and the occurrence of heart disease especially I/R, so that medicinal plants and 
their compounds can decrease cardiac ischemia injury via several pathways in the heart and other 
organs like the kidney. The mechanisms involved include dilating coronary arteries, enhancement of 
antioxidant enzymes such as SOD and GPX and increased oxygen supply to the heart. Subsequently 
there is increased cardiac contractility, reduction of blood pressure, cholesterol, triglyceride, 
cholesterol, LDL, lipid peroxidation, MDA, prostaglandins, necrosis, inflammation, myocardial infarct 
size, arrhythmias, platelet accumulation, fibrinolytic effects, clot lysis, cardiac enzymes as well as 
increase in HDL, and apolipoprotein A and expression of anti-apoptotic genes. In summary, medicinal 
plants are beneficial in ischemic heart disease through various mechanisms, and patients with these 
diseases are recommended to use them. 
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